Caisse Des Depots ET Consignations Sells 7,037 Shares of Cardinal Health, Inc. $CAH

Caisse Des Depots ET Consignations reduced its position in Cardinal Health, Inc. (NYSE:CAH) by 20.8% during the fourth quarter, HoldingsChannel reports. The firm owned 26,814 shares of the company’s stock after selling 7,037 shares during the period. Caisse Des Depots ET Consignations’ holdings in Cardinal Health were worth $5,510,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of CAH. Wellington Management Group LLP boosted its stake in shares of Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares during the last quarter. Holocene Advisors LP boosted its stake in shares of Cardinal Health by 141.4% in the 3rd quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock valued at $302,332,000 after purchasing an additional 1,128,358 shares during the last quarter. Barclays PLC boosted its stake in Cardinal Health by 109.3% during the third quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock worth $248,658,000 after acquiring an additional 827,446 shares in the last quarter. SG Americas Securities LLC boosted its stake in Cardinal Health by 3,829.1% during the fourth quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock worth $149,504,000 after acquiring an additional 708,995 shares in the last quarter. Finally, Victory Capital Management Inc. boosted its stake in Cardinal Health by 44.9% during the third quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after acquiring an additional 707,495 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q3 non?GAAP earnings beat estimates and company raised FY?2026 guidance to $10.70–$10.80, above consensus — the core bullish catalyst. PR Newswire: Q3 Results & Outlook
• Positive Sentiment: Company executed $250M additional share repurchase (bringing FY26 repurchases to $1.0B) and reduced debt — shareholder?friendly actions that support the share price. PR Newswire: Buybacks & Debt Reduction
• Neutral Sentiment: Wells Fargo cut its price target from $256 to $245 but kept an “overweight” rating, signaling continued analyst confidence despite the trim. Benzinga: Wells Fargo PT Change
• Neutral Sentiment: Full earnings call and transcripts are available for investors who want details on segment performance and management commentary. Yahoo Finance: Earnings Transcript Seeking Alpha: Call Transcript
• Negative Sentiment: Revenue missed expectations ($60.9B reported vs. ~$62.1B est.), which prompted media coverage and short?term selling pressure despite the EPS beat. Benzinga: Revenue Miss Coverage
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and GAAP EPS declined, driven in part by a $184M pre?tax goodwill impairment in the Navista & ION reporting unit — a one?time charge that reduces headline profitability. PR Newswire: Goodwill Impairment
• Negative Sentiment: Several outlets highlighted the “mixed” nature of the report (EPS/guidance vs. revenue/GAAP weakness), which can increase volatility and keep some investors on the sidelines. CNBC: Mixed Results Coverage

Analysts Set New Price Targets

Several brokerages recently issued reports on CAH. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Monday, April 20th. Wells Fargo & Company cut their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research note on Friday. William Blair began coverage on shares of Cardinal Health in a research note on Tuesday. They set an “outperform” rating on the stock. JPMorgan Chase & Co. increased their target price on shares of Cardinal Health from $209.00 to $243.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 10th. Finally, Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $243.67.

Cardinal Health Trading Up 1.2%

CAH opened at $195.13 on Friday. The company’s fifty day moving average price is $213.73 and its two-hundred day moving average price is $205.46. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The company has a market cap of $45.92 billion, a price-to-earnings ratio of 28.08, a PEG ratio of 1.19 and a beta of 0.53.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter in the prior year, the company posted $2.35 earnings per share. The business’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts forecast that Cardinal Health, Inc. will post 10.79 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st were issued a dividend of $0.5107 per share. The ex-dividend date was Wednesday, April 1st. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health’s dividend payout ratio is presently 29.35%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.